Fundraising Fox

Tessera

191 employees on LinkedIn · 11 known investors

Find your way into Tessera

596 people in our graph share verified history with the Tessera team — schools, employers, funds. One of them is your warm intro.

Wesley Chanunlockedknows Geoffrey von Maltzahn · together at Massachusetts Institute of Technology (overlapped)
×8knows the team · via Massachusetts Institute of Technology
knows the team · via Lila Sciences
knows the team · via Flagship Pioneering
knows the team · via Sana Biotechnology

Tessera Therapeutics develops Gene Writing, a genome engineering technology platform designed to make permanent alterations to the human genome for treating diseases. The company focuses on non-viral delivery methods to enable potentially curative genetic therapies.

Founders & leadership

GVGeoff von Maltzahn
Geoff von Maltzahnin𝕏Founding CEO, Chairman of BoardGeoff von Maltzahn is founder and CEO of Tessera Therapeutics, a company developing Gene Writing technology for genome engineering. He previously served as CTO of Seres Therapeutics and has founded or led multiple biotechnology companies including Generate:Biomedicines, Indigo Agriculture, and Kaleido Biosciences.
JR
Joseph RomanelliCEO

Investors · 11

Founder mafia

2 people who came through Tessera went on to found or lead other companies.

In the news

Frequently asked questions

What does Tessera do?
Tessera Therapeutics develops Gene Writing, a genome engineering technology platform designed to make permanent alterations to the human genome for treating diseases. The company focuses on non-viral delivery methods to enable potentially curative genetic therapies.
Who founded Tessera?
Tessera was founded by Geoff von Maltzahn.
Who are Tessera's investors?
Tessera's investors include Artis Ventures, Flagship Pioneering, March Capital Partners, OMX Ventures, SoftBank Vision Fund, Solari Capital, Toba Capital, Andreessen Horowitz and 3 more.